Literature DB >> 12229948

Pelvic radiation and anorectal function: introducing the concept of sphincter-preserving radiation therapy.

Pascal A Gervaz1, Steven D Wexner, John H Pemberton.   

Abstract

Mesh：

Year:  2002        PMID： 12229948     DOI： 10.1016/s1072-7515(02)01308-x

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN： 1072-7515            Impact factor:   6.113


× No keyword cloud information.
  7 in total

1.  Neoadjuvant radiochemotherapy for patients with locally advanced rectal cancer leads to impairment of the anal sphincter.

Authors:  Joerg Theisen; Werner K-H Kauer; Hjalmar Nekarda; Ludwig Schmid; Hubert J Stein; Joerg-Ruediger Siewert
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

2.  Health-related quality of life, faecal continence and bowel function in rectal cancer patients after chemoradiotherapy followed by radical surgery.

Authors:  Salvatore Pucciarelli; Paola Del Bianco; Fabio Efficace; Paola Toppan; Samantha Serpentini; Maria Luisa Friso; Sara Lonardi; Gian Luca De Salvo; Donato Nitti
Journal:  Support Care Cancer       Date:  2009-07-23       Impact factor: 3.603

Review 3.  Multidisciplinary treatment of rectal cancer in 2014: where are we going?

Authors:  Andrea Vignali; Paola De Nardi
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

4.  Relationships between dose to the gastro-intestinal tract and patient-reported symptom domains after radiotherapy for localized prostate cancer.

Authors:  Maria Thor; Caroline E Olsson; Jung Hun Oh; Stine E Petersen; David Alsadius; Lise Bentzen; Niclas Pettersson; Ludvig P Muren; Ann-Charlotte Waldenström; Morten Høyer; Gunnar Steineck; Joseph O Deasy
Journal:  Acta Oncol       Date:  2015-09-04       Impact factor: 4.089

Review 5.  A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.

Authors:  Yi Li; Ji Wang; Xiaowei Ma; Li Tan; Yanli Yan; Chaofan Xue; Beina Hui; Rui Liu; Hailin Ma; Juan Ren
Journal:  Int J Biol Sci       Date:  2016-07-17       Impact factor: 6.580

6.  Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer.

Authors:  Surennaidoo P Naiken; Christian Toso; Laura Rubbia-Brandt; Theodoros Thomopoulos; Arnaud Roth; Gilles Mentha; Philippe Morel; Pascal Gervaz
Journal:  BMC Surg       Date:  2014-01-17       Impact factor: 2.102

7.  A multicentre cohort study assessing the utility of routine blood tests as adjuncts to identify complete responders in rectal cancer following neoadjuvant chemoradiotherapy.

Authors: 
Journal:  Int J Colorectal Dis       Date:  2022-03-24       Impact factor: 2.796
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.